506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment - Contacts and Locations

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

This study is ongoing, but not recruiting participants.

Study NCT00004239. Last updated on November 16, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004239

Locations


United States, Illinois
	University of Chicago Cancer Research Center
	Chicago, Illinois, United States, 60637-1470

United States, Iowa
	Holden Comprehensive Cancer Center at The University of Iowa
	Iowa City, Iowa, United States, 52242-1009

United States, North Carolina
	Comprehensive Cancer Center at Wake Forest University
	Winston-Salem, North Carolina, United States, 27157-1082

Sponsors and Collaborators

Cancer and Leukemia Group B

National Cancer Institute (NCI)

Investigators


Study Chair:	Todd M. Zimmerman, MD	University of Chicago